DOCSLIB.ORG

ISO 9001:2000 Certified

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ISO 9001:2000 Certified Catalog X ISO 9001:2000 Certified 1801 Commerce Drive • South Bend, Indiana 46628 • 800-729-5270 • www.enzymeresearch.com Human Coagulation Bovine Coagulation Zymogens Zymogens • Human Prothrombin • Bovine Protein C • Human Factor VII • Bovine Prothrombin • Human Protein C • Bovine Factor IX • Human Factor IX • Bovine Factor X • Human Factor X • Bovine Plasminogen • Human Factor XI • Human Factor XII Enzymes • Human Factor XIII • Human Prekallikrein • Bovine Activated Protein C • Sing. Chain High Molecular Wt. Kininogen • Bovine Alpha-Thrombin • Two Chain High Molecular Wt. Kininogen • Bovine Factor IXa Alpha • Human Glu-Plasminogen • Bovine Factor IXa Beta • Human Lys-Plasminogen • Bovine Factor Xa • Bovine Factor XIa Enzymes CoFactors • Human Alpha Thrombin • Human Gamma Thrombin • Bovine Factor V/Va • Human Factor VIIa • Human Activated Protein C Inhibitors • Human Factor IXa Alpha • Human Factor IXa Beta • • Human Factor Xa Bovine Antithrombin • Human Factor XIa • Human Factor Alpha-XIIa Platelets and Plasma Proteins • Human Factor XIIIa • Human Kallikrein • Bovine Fibrinogen, Plasminogen Depleted • Human Plasmin Antibodies CoFactors • Monoclonal • Human Protein S • Polyclonal • Human Protein Z • Paired Antibodies • Human Fibronectin Inhibitors Venoms • Human Antithrombin • Russell's Viper Venom • Human Heparin CoFactor II • Corn Trypsin Inhibitor Other Species Proteins • a2 Antiplasmin • TAFI • Canine Proteins • Murine Proteins Platelets & Plasma Proteins • Porcine Proteins • Rabbit Proteins • Human Fibrinogen 1 2 & 3 • Rat Proteins • Human GPIIbIIIa • Apolipoprotein • Platelet Factor 4 Worldwide Distributors Des-Gla & Inactivated Proteins Technical Information • Des-Gla Proteins • Inactivated Proteins For orders in the United States, please contact our U.S. office. All other orders may be placed through the nearest distributor listed below. United States United Kingdom Enzyme Research Laboratories, Ltd. Enzyme Research Laboratories, Inc. 15 Sketty Road, Swansea, UK SA2 OEU United Kingdom 1801 Commerce Drive, South Bend, IN 46628 Tel: +44 1792 466166 • Fax: +44 1792 466366 Tel: 574-288-2268 • Fax: 574-288-2272 Contact: Sales Department • Email: [email protected] Contact: [email protected] Website: www.enzymeresearch.co.uk Australia Japan Banksia Scientific Cosmo Bio Company Unit 3, 160 Lytton Rd (P.O. Box 529) 2-2-20, Toyo Koto-ku Bulimba QLD 4171 Australia Tokyo, 135 Japan Tel: +61 7 3902 3000 • Fax: +61 7 3217 9869 Tel: 813 5632 9610 • Fax: 813 5632 9619 Free call 1300 769944 Contact: Support Team Contact: Mr. Stephen Edwards Email: [email protected] Email: [email protected] Website: www.cosmobio.co.jp Website: www.banksiascientific.com.au Austria Switzerland Coa. Chrom Diagnostica, GmbH Milan Analytica, AG 1080 Vienna, Austria Obere Egg 2, CH-4312 Magden, Switzerland Tel: +43 1 699 97 97 • Fax: +43 1 699 18 97 Tel. +41 61 845 9988 • Fax. +41 61 845 9987 Contact: Mr. Bernhard Kolmer Contact: Dr. Alfred Lampart Email: [email protected] Email: [email protected] Website: www.coachrom.com Website: www.milananalytica.ch Finland, Norway, Sweden Diagnostica & Analys Service AB the Netherlands, Belgium, France, Carl Wilhelmsonsvag 7 Switzerland, Denmark SE 416 56 Goteburg Sweden Kordia - PO Box 4018 Tel. +46 31 25 26 28 • Fax. +46 31 21 26 28 NL-2301 RA Leiden, the Netherlands Contact: Dr. Petter Friberger Tel. +31 71 523 10 50 • Fax. +31 71 522 17 00 Email: [email protected] Contact: Edward van Poort and Erik van Megen Website: www.dia-service.se Email: [email protected] Website: www.kordia.nl or www.kordia.com Germany Haemochrom Diagnostica GmbH Belgium: Kordia - PO Box 4018 Renteilichtung 1 NL-2301 RA Leiden, the Netherlands Essen, Germany DE-45134 Tel. Bruxelles: 02-42-685-12 Tel. +49 201 843 770 • Fax. +49 201 536 456 Fax Bruxelles: 02-42-801-09 Contact: Dr. Birgit Bakowski-Enzian Email: [email protected] Email: [email protected] Website: www.kordia.be Website: www.haemochrom.de Israel France: Kordia - PO Box 4018 Tarom Applied Technologies Ltd. NL-2301 RA Leiden, Pays Bas Petach Tikva Israel 49517 Tel. France: 0380 20 69 93 Tel. +972 3 9214145 • Fax.+972 3 9214146 Fax France: 0380 20 69 94 Contact: Mr. Zvi Barr Email: [email protected] Email: [email protected] Website: www.kordia.fr Website: www.tarom.co.il Italy Cabru s.a.s. Via Forlanini 52 20043 Arcore (M ) Italy B Tel. +39 039 60 13 988 • Fax. +39 039 60- 14 284 Contact: Dr. Bruno Casagrande Email: [email protected] Website: www.cabru.it TECHNICAL INFORMATION Protein Handling Enzyme Research Laboratories, Inc. makes the following suggestions for the storage and handling of purified proteins 1. Most purified proteins are stable at low temperatures and should be stored at <-60°C. 2. Lyophilized proteins should be reconstituted using a good laboratory quality H2O. After reconstitution the protein should be aliquoted into a useful (one time use) size and stored at <-60°C. 3. Freeze proteins in a concentrated form and as soon as possible. When dilution is necessary, dilute immediately prior to use. When possible, dilution buffers should contain stabilizers such as albumin. 4. Limit thawing and refreezing. Multiple thaw/freezes can reduce protein activity and cause degradation. We always suggest aliquoting the protein into a single use size. 5. Refrigerate thawed proteins or store on ice. Proteins warmed even to room temperature may degrade quickly. Refreeze proteins as soon as possible. 6. One exception to # 5 is Fibrinogen. After thawing Fibrinogen, keep at room temperature. Fibrinogen will come out of solution if it is cooled. 7. Products provided in Glycerol/buffer solutions should be stored at -20°C. Temperatures below -30°C can cause phase transitions and need to be avoided. Unit Definition 1 PEU is equal to the amount of activity found in mL of plasma as determined in factor deficient clotting assay. All extinction coefficients are reported for 280 nm using 1 cm path length. Shipping Information Unless otherwise noted, all the coagulation factors are stored at <-60°C and shipped on dry ice by overnight carrier. Shipping will be billed to customer for orders under $2000. All Human Source material is tested and found negative for all communicable diseases, including HIV-1 and HIV-2 antibodies, HCV, Rapid Plasma Reagin and Hepatitis B Surface Antigen. Because no test method can offer complete assurance that Human Immunodeficiency Virus (HIV), Hepatitis B virus or other infectious agents are absent, all human proteins should be handled as suggested in the U.S. Department of Health and Human Services Manual on Biosafety in Microbiological & Biomedical Laboratories. Back to Index Human Prothrombin HP 1002 Human Prothrombin (Factor II) Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Buffer composition = 20 mM Tris-HCl/0.1 M NaCl/pH 7.4 *Extinction Coefficient (1%) = 13.6 One unit = 90 µg Molecular Weight =72,000 daltons Also available: des-Gla-Human Prothrombin and Prothrombin Fragment 1 and 2 Human Factor VII HFVII 1007 Human Factor VII (Proconvertin) Prepared from fresh frozen human plasma. Human Factor VII is a single-chain vitamin K dependent glycoprotein found in trace quantities in plasma (0.5 mg/Liter). In the Tissue Factor Pathway of coagulation, Human Factor VIIa, in the presence of calcium ions and tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa. Buffer composition =20 mM Tris-HCl/0.1 M NaCl/1 mM Benzamidine/pH 7.4 *Extinction Coefficient (1%) = 13.9 Molecular Weight = 50,000 daltons Human Protein C HPC 1001 Human Protein C Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa. Buffer composition = 20 mM Tris-HCl/0.1 M NaCl/1 mM Benzamidine/pH 7.4 *Extinction Coefficient (1%) = 14.5 Molecular Weight = 62,000 daltons Also available: des-Gla-Human Protein C Back to Table of Contents Human Factor IX HFIX 1009 Human Factor IX (Christmas Factor) Prepared from fresh frozen human plasma. This protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay. Human Factor IX, activated by either the Contact or Tissue Factor Pathway, is responsible for the activation of Factor X to Xa. Buffer composition: 20 mM Tris-HCl/0.1 M NaCl /1 mM Benzamidine/pH 7.4 *Extinction Coefficient (1%) = 13.2 One unit = 5 µg Molecular Weight = 56,000 daltons Human Factor X HFX 1010 Human Factor X (Stuart Prower Factor) Prepared from fresh frozen human plasma. The purity of this Vitamin K dependent protein is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay. Human Factor X, once activated via the Contact Factor Pathway or the Tissue Factor Pathway, is responsible for the conversion of Prothrombin to Thrombin. Buffer composition 20 mM Tris-HCl/0.1 M NaCl /1 mM Benzamidine/pH 7.4 *Extinction Coefficient (1%) =11.6 One unit =8 µg Molecular Weight =58,800 daltons Also available: des-Gla-Human Factor Human Factor XI HFXI 1111 Human Factor XI (Plasma Thromboplastin Antecedent) Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons. The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.
Load more

Recommended publications
  • Clotting Phenomena at the Blood-Polymer Interface and Development of Blood Compatible Polymeric Surfaces
    Clotting Phenomena at the Blood-Polymer Interface and Development of Blood Compatible Polymeric Surfaces Adriaan Bantjes In the past two decades many attempts have been made to relate surface and interfacial parameters with the blood compatibility of polymeric surfaces. It is however doubtful if by a single parameter the behaviour of blood on a surface can be predicted. Two major aspects of blood compatibility -- the prevention of platelet adhesion and the deactivation of the intrinsic coagulation system are determined by the measure and nature of competi- tive blood protein adsorption on the foreign surface. The adhesion of blood platelets is promoted by adsorbed fibrinogen and gamma globulin, while adsorbed albumin inhibits platelct adhesion. Heparinised surfaces do not adsorb fibrin and consequently no adhesion of platelets takes place. Othcr surfaces with low platelct adhesion are the hydrogels, certain block copolyetherurethanes, polyelectrolyte complexes and biolised proteins. Heparinised surfaces of the cationically bonded type inhibit the intrinsic coagulation as well, however this may be due to unstable coatings and heparin leakage. In the authors laboratory a synthetic heparinoid was prepared with the structure - [CH, - C(CH3) NHS03Na ~ C(H) COONa ~ CH2 --] with h, = (7.5 5 1 .O) x lo5 and an in vivo anticoagulant activity of 50% of heparin. Its coatings on PVC, using tridodecyltiietliyl-ammoniuni chloridc as a coupling agent, are stable in plasma and salt solutions and provide surfaces which show negligible platelet adhesion and a strong inhibition 01 the intrinsic coagulation on contact with blood. Similar results were found with polydimethylsiloxane surfaces coated with this heparinoid. 1. INTRODUCTION new blood compatible materials may be developed it is necessary to explain sotne of the mechanisms of blood co- The clinical use of blood contacting devices and prosthcses is agulation on intcraction with a foreign surface.
    [Show full text]
  • The Effect of Gamma Globulin in Pustular Acne*
    PRELIMINARY AND SHORT REPORT THE EFFECT OF GAMMA GLOBULIN IN PUSTULAR ACNE* LOREN W.SHAFFER,M.D., BENJAMIN SdHWIMMER, M.D. AND RENATO J.STANICCO,M.D. One of us (LWS) bad occasion to treat a young Clinical Response: Patient 1: New lesions ceased white man with gamma globulin for prophylaxisappearing immediately after the first injection. after exposure to infectious hepatitis. He wasBy the third week most of the cystic and pustular given two injections, 10 cc. each, of human Polio-lesions had dried up, and no new ones had ap- myelitis Immune Globulin, one week apart. Itpeared. Comedones were not decreased in number. was observed that shortly after the second injec-The patient maintained his improvement through tion, his severe pustular and indurated acnethe fifth week when the cystic and pustular lesions improved considerably. This observation led tobegan to recur. the present study, of which this is a preliminary Patient 2: New lesions continued to develop report. throughout the period of treatment and the one This study of the therapeutic effect of gammamonth follow up. globulin in pustular acne is coupled with a study Patient 3: There was no observable effect of of the serum protein and C-reactive protein levelstreatment. before and after treatment. Patient 4: The first improvement was seen in Method: Four patients in their late teens, other-the second week and by the third, all cystic and wise healthy, but with severe pustular and cysticpustular lesions were dry. The improvement acne that had been resistant to conventionallasted for two weeks after which the lesions methods of treatment were selected for the study.began to return.
    [Show full text]
  • Gamma Globulin”
    CLINICAL APPLICATION OF A SIMPLE METHOD FOR ESTIMATING “GAMMA GLOBULIN” B. V. Jager, Margaret Nickerson J Clin Invest. 1948;27(2):231-238. https://doi.org/10.1172/JCI101938. Research Article Find the latest version: https://jci.me/101938/pdf CLINICAL APPLICATION OF A SIMPLE METHOD FOR ESTIMATING "GAMMA GLOBULIN" 1 By B. V. JAGER AND MARGARET NICKERSON (From the Department of Medicine, School of Medicine, University of Utah, Salt Lake City) (Received for publication August 11, 1947) The electrophoretic technique offers the most cipitate is finely emulsified in 3.0 ml. of 33.3 per cent accurate method for serum fractionation. This saturated ammonium sulfate. The tube is recentrifuged for 30 minutes and the supernatant fluid is discarded. permits a quantitative separation of serum into The precipitate is dissolved in 10 ml. of saline and an albumin and into three major globulin fractions aliquot is employed to determine its protein content, using which are designated as alpha, beta and gamma a biuret method such as that of Weichselbaum (2). components. In recent years electrophoretic anal- Triplicate determinations may be made with an *yses of serum proteins have been performed by accuracy of + 2 per cent. Electrophoretic studies many investigators in a variety of diseases. The indicate that 73 to 83 per cent of this protein accumulated data from these studies have now at- fraction consists of gamma globulin, the remainder tained sufficient size and agreement that they may consisting of alpha and beta globulins. From 70 to be of value as an aid in the differential diagnosis 82 per cent of the total gamma globulin present of certain diseases or for following the course of in the serum is recovered in this fraction.
    [Show full text]
  • Modeling to Understand Plant Protein Structure-Function Relationships—Implications for Seed Storage Proteins
    molecules Review Modeling to Understand Plant Protein Structure-Function Relationships—Implications for Seed Storage Proteins 1,2, 1, 2 1, Faiza Rasheed y, Joel Markgren y , Mikael Hedenqvist and Eva Johansson * 1 Department of Plant Breeding, The Swedish University of Agricultural Sciences, Box 101, SE-230 53 Alnarp, Sweden; [email protected] (F.R.); [email protected] (J.M.) 2 School of Chemical Science and Engineering, Fibre and Polymer Technology, KTH Royal Institute of Technology, SE–100 44 Stockholm, Sweden; [email protected] * Correspondence: [email protected] These authors contributed equally to this work. y Received: 2 January 2020; Accepted: 14 February 2020; Published: 17 February 2020 Abstract: Proteins are among the most important molecules on Earth. Their structure and aggregation behavior are key to their functionality in living organisms and in protein-rich products. Innovations, such as increased computer size and power, together with novel simulation tools have improved our understanding of protein structure-function relationships. This review focuses on various proteins present in plants and modeling tools that can be applied to better understand protein structures and their relationship to functionality, with particular emphasis on plant storage proteins. Modeling of plant proteins is increasing, but less than 9% of deposits in the Research Collaboratory for Structural Bioinformatics Protein Data Bank come from plant proteins. Although, similar tools are applied as in other proteins, modeling of plant proteins is lagging behind and innovative methods are rarely used. Molecular dynamics and molecular docking are commonly used to evaluate differences in forms or mutants, and the impact on functionality.
    [Show full text]
  • Leukocytic Function in Hypogammaglobulinemia
    Leukocytic function in hypogammaglobulinemia Ira D. Mickenberg, … , Richard K. Root, Sheldon M. Wolff J Clin Invest. 1970;49(8):1528-1538. https://doi.org/10.1172/JCI106370. Research Article The phagocytic, bactericidal, and metabolic capabilities of circulating blood leukocytes from three adults (two males, one female) with hypogammaglobulinemia and recurrent pneumonia, chronic sinusitis, and intestinal giardiasis were studied. These functions were found to be normal when leukocytes from the patients were incubated in media containing normal human serum. Phagocytosis of Staphylococcus albus and polystyrene balls by both patient and normal leukocytes was diminished when the cells were incubated in hypogammaglobulinemic plasma. A similar defect in opsonization by patient plasma was also noted for pneumococci, Escherichia coli and variably with Staphylococcus aureus. Both patient and normal sera had equivalent levels of heat-labile S. albus opsonins; normal serum, however, contained heat-stable S. albus-specific absorbable opsonins in significantly greater quantities to account for its superior opsonic capacity. The addition of commercial gamma globulin or purified IgG to hypogammaglobulinemic sera restored full S. albus opsonic activity. The relevancy of these observations to the impaired host defenses in these patients will be discussed. Find the latest version: https://jci.me/106370/pdf Leukocytic Function in Hypogammaglobulinemia IRA D. MIcKENBERG, RICHARD K. ROOT, and SmELON M. WOLFF From the National Institutes of Health, National
    [Show full text]
  • Quantitative Studies of the Effect of Red-Blood- Cell Sensitization on in Vivo Hemolysis
    QUANTITATIVE STUDIES OF THE EFFECT OF RED-BLOOD- CELL SENSITIZATION ON IN VIVO HEMOLYSIS M. Constantoulakis, … , R. S. Schwartz, W. Dameshek J Clin Invest. 1963;42(11):1790-1801. https://doi.org/10.1172/JCI104864. Research Article Find the latest version: https://jci.me/104864/pdf Journal of Clinical Investigation Vol. 42, No. 11, 1963 QUANTITATIVE STUDIES OF THE EFFECT OF RED-BLOOD-CELL SENSITIZATION ON IN VIVO HEMOLYSIS * By M. CONSTANTOULAKIS,t N. COSTEA,4 R. S. SCHWARTZ, AND W. DAMESHEK (From the Blood Research Laboratory, Pratt Clinic-New England Center Hospital, and the Department of Medicine, Tufts University School of Medicine, Boston, Mass.) (Submitted for publication January 22, 1963; accepted July 29, 1963) Although a positive antiglobulin reaction is a butes, both isoantibodies and autoantibodies had characteristic and distinctive feature of autoim- qualitatively distinctive effects on red-cell survival. mune hemolytic anemia (AIHA), the precise role of the erythrocyte-sensitizing globulin in the MATERIALS AND METHODS pathogenesis of this disease is poorly understood. Patients. Seventeen patients with AIHA of the Earlier studies have suggested that the severity "warm" antibody variety were studied; 11 were "idio- of hemolysis in AIHA is a function of the quan- pathic," and the rest had systemic lupus erythematosus tity of globulin adherent to the red blood cells (2), chronic lymphocytic leukemia (3), or Hodgkin's (1); direct estimation of the amount of disease (1). Characteristics of the individual cases are however, shown in Table I. autoantibody was possible in only a few cases. Isoantibodies. The anti-D and anti-Kell sera were of There is, in addition, a lack of quantitative data the incomplete, noncomplement-binding variety.' concerning the effects of isoantibodies on erythro- Eluates were prepared by Fudenberg, Barry, and cyte survival.
    [Show full text]
  • Serum & Urine Protein Electrophoresis
    Serum & urine protein electrophoresis Take a test Normal or abnormal? Definitions Electrophoresis is a method of separating proteins based on their physical properties. Serum is placed on a specific medium, and a charge is applied. The net charge (positive or negative) and the size and shape of the protein commonly are used in differentiating various serum proteins. Definitions Several subsets of serum protein electrophoresis are available. The proteins are stained, and their densities are calculated electronically to provide graphical data on the absolute and relative amounts of the various proteins. Further separation of protein subtypes is achieved by staining with an immunologically active agent, which results in immunofluorescence and immunofixation. Components of Serum Protein Electrophoresis The pattern of serum protein electrophoresis results depends on the fractions of two major types of protein: albumin and globulins. Components of Serum Protein Electrophoresis Albumin, the major protein component of serum, is produced by the liver under normal physiologic conditions. Globulins comprise a much smaller fraction of the total serum protein content. The subsets of these proteins and their relative quantity are the primary focus of the interpretation of serum protein electrophoresis. Components of Serum Protein Electrophoresis Albumin, the largest peak, lies closest to the positive electrode. The next five components (globulins) are labeled alpha1, alpha2, beta1, beta2, and gamma. The peaks for these components lie toward the negative electrode, with the gamma peak being closest to that electrode. serum protein electrophoresis normal pattern ALBUMIN The albumin band represents the largest protein component of human serum. The albumin level is decreased under circumstances in which there is less production of the protein by the liver or in which there is increased loss or degradation of this protein.
    [Show full text]
  • Understanding and Interpreting Serum Protein Electrophoresis THEODORE X
    Understanding and Interpreting Serum Protein Electrophoresis THEODORE X. O’CONNELL, M.D., TIMOTHY J. HORITA, M.D., and BARSAM KASRAVI, M.D. Kaiser Permanente Woodland Hills Family Medicine Residency Program, Woodland Hills, California Serum protein electrophoresis is used to identify patients with multiple myeloma and other serum protein disorders. Electrophoresis separates proteins based on their physical proper- ties, and the subsets of these proteins are used in interpreting the results. Plasma protein levels display reasonably predictable changes in response to acute inflammation, malignancy, trauma, necrosis, infarction, burns, and chemical injury. A homogeneous spike-like peak in a focal region of the gamma-globulin zone indicates a monoclonal gammopathy. Monoclonal gammopathies are associated with a clonal process that is malignant or potentially malignant, including mul- tiple myeloma, Waldenström’s macroglobulinemia, solitary plasmacytoma, smoldering multiple myeloma, monoclonal gammopathy of undetermined significance, plasma cell leukemia, heavy chain disease, and amyloidosis. The quantity of M protein, the results of bone marrow biopsy, and other characteristics can help differentiate multiple myeloma from the other causes of monoclonal gammopathy. In contrast, polyclonal gammopathies may be caused by any reac- tive or inflammatory process. (Am Fam Physician 2005;71:105-12. Copyright© 2005 American Academy of Family Physicians.) See page 27 for levels-of- erum protein electrophoresis is a lab- Several subsets of serum protein electro- evidence definitions. oratory examination that commonly phoresis are available. The names of these is used to identify patients with mul- subsets are based on the method that is used tiple myeloma and other disorders of to separate and differentiate the various S serum protein.
    [Show full text]
  • Gamma Globulin
    MAY 26, 1945 BRITISH 73 TRINITROTOLUENE MEICALMEDICAL J OURNAL 739 presence in the urine of animals fed on a-T.N.T. of throat. The symptoms came on after an initial period 2: 6 dinitro-4-hydroxylaminotoluene, 2 6 dinitro-4-amino- when there was an increased sense of well-being accom- toluene, and 2: 4 dinitro-6-aminotoluene (which may be panied by a voracious appetite. There was evidence of estimated accurately by spectrophotometric methods7) haemolysis in over 85 % of the students, with a fall in points to some reduction mechanism. T.N.T. may also haemoglobin, red cell, and haematocrit readings. There be oxidized: experiments with trinitrobenzyl alcohol in were also an increase in reticulocytes, bilirubinaemia with attempts to establish the origin of the red pigment indicate urobilinuria, and a marked erythroblastic response in the the probable existence of such a mechanism, since only marrow. As Noro found, the reticulocyte response was a-T.N.T. and 2 : 4: 6 : trinitrobenzyl alcohol would cause not maximal until a few days after exposure had ceased. excretion of red pigment. Present knowledge of detoxica- This suggests that T.N.T., in addition to a destructive action tion mechanisms suggests that the glucuronides of T.N.T. on the circulating red cells, also affects the bone marrow. urine must arise from T.N.T. oxidation products: they are probably trinitrobenzyl glucuronide,.or dinitroaminobenzyl glucuronide, or a mixture of both. The hydroxylamine GAMMA GLOBULIN derivative provides an example of the making of a more toxic product in a detoxication mechanism, and it is a The story of how human blood has been harnessed to powerful former of methaemoglobin in vitro.
    [Show full text]
  • Reports 1017 Number 12
    Volume 15 Reports 1017 Number 12 Fig. 2. Trahecular meshwork from choroidal melanoma case 3, showing immunofluorescent staining for complement component C3. angle glaucoma. They observed cell-mediated im- of glaucomatous eyes, Arch. Ophthalmol. 68: munity, as indicated by leukocyte migration in- 643, 1962. hibition in only three of 10 patients with open- 2. Becker, B., Uneer, H-H., Coleman, S. L., et angle glaucoma and no other ocular diseases. al.: Plasma cells and gamma-globulin in tra- Evidence which may link open-angle glaucoma becular meshwork of eyes with primary open- to immunologic abnormalities include the obser- angle glaucoma, Arch. Ophthalmol. 70: 38, 1963. vation that such patients have a higher incidence 3. Myers, R. L.: Cell-mediated immunity: rele- of positive antinuclear antibody reaction (44 per vance to ocular diseases (Editorial on Recent cent), compared with nonglaucomatous controls Advances), INVEST. OPHTHALMOL. 14: 635, (7.5 per cent) and gg topical steroid responders 1975. (7 per cent).8 Also, certain HL-A antigens ap- 4. Leopold, I. H.: Clinical immunology in oph- pear in a higher percentage of open-angle glau- thalmology, Am. J. Ophthalmol. 81: 129, 1976. coma patients than in the normal population." 5. Allansmith, M. R., Whitney, C. R., McClellan, These studies differ, however, as to which of the B. H., et al.: Immunoglobulin in the human HL-A antigens are abnormally increased. Co- eye, Arch. Ophthalmol. 89: 36, 1973. operative studies are currently underway to more 6. Allansmith, M. R.: Personal communication. 7. Henley, W. L., Okas, S., and Leopold, I. H.: clearly define this question and to establish its Cellular immunity in chronic ophthalmic dis- significance in open-angle glaucoma, orders.
    [Show full text]
  • Gamma Globulin As a Prophylactic and Therpeautic Agent In
    GAMMA GLOBULIN AS A PROPHYLACTIC AND THERAPEUTIC AGENT IN COMMUNICABLE DISEASE* W il l ia m B erenberg, M.D.1 A. P lasm a F ractionation RANSFUSION of whole blood has long been employed for numerous conditions, such as hemorrhage, anemia, T debility, infection, hypoproteinemia, thrombocytopenia, and hemophilia. Blood is a complex mixture of multiple ele­ ments with different properties and physiological activities. The desired clinical effect of its transfusion usually depends on the physiological function of a single component. Actually in only one situation, hemorrhage, are all the constituents of blood required to repair the physiologic defect. In most other in­ stances, it would be more rational to employ only that com­ ponent of blood whose physiological function was desired. Methods for the fractionation of plasma (1) (2) have evolved which permit the chemical isolation of several of its known constituents in a form suitable for clinical use. Thus it not only is more rational to employ these preparations to obtain the desired effect, but it allows the clinician to use larger amounts of the active fraction in order to achieve a more rapid and effective result. It also is obviously more economical to use only the desired fraction and not whole blood, thus leaving the various other fractions to be employed in other patients where their use is specifically indicated by their various physiological requirements. Following this philosophy, whole blood may be centrifuged, the plasma separated and the red blood cells resuspended in saline to be employed in the treatment of those anemias where the defect is one primarily of insufficient numbers of red blood cells.
    [Show full text]
  • University Microfilms International 300 N
    INFORMATION TO USERS This was produced from a copy of a document sent to us for microfilming. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality o f the material submitted. The following explanation of techniques is provided to help you understand markings or notations which may appear on this reproduction. 1. The sign or “target” for pages apparently lacking from the document photographed is “ Missing Page(s)” . If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting through an image and duplicating adjacent pages to assure you of complete continuity. 2. When an image on the film is obliterated with a round black mark it is an indication that the film inspector noticed either blurred copy because of movement during exposure, or duplicate copy. Unless we meant to delete copyrighted materials that should not have been filmed, you will find a good image of the page in the adjacent frame. If copyrighted materials were deleted you will find a target note listing the pages in the adjacent frame. 3. When a map, drawing or chart, etc., is part of the material being photo­ graphed the photographer has followed a definite method in “sectioning” the material. It is customary to begin filming at the upper left hand corner of a large sheet and to continue from left to right in equal sections with small overlaps. If necessary, sectioning is continued again—beginning below the first row and continuing on until complete.
    [Show full text]